These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 22322899)

  • 1. Inclusion complex of novel curcumin analogue CDF and β-cyclodextrin (1:2) and its enhanced in vivo anticancer activity against pancreatic cancer.
    Dandawate PR; Vyas A; Ahmad A; Banerjee S; Deshpande J; Swamy KV; Jamadar A; Dumhe-Klaire AC; Padhye S; Sarkar FH
    Pharm Res; 2012 Jul; 29(7):1775-86. PubMed ID: 22322899
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the host-guest complex of a curcumin analog with β-cyclodextrin and β-cyclodextrin-gemini surfactant and evaluation of its anticancer activity.
    Poorghorban M; Das U; Alaidi O; Chitanda JM; Michel D; Dimmock J; Verrall R; Grochulski P; Badea I
    Int J Nanomedicine; 2015; 10():503-15. PubMed ID: 25609956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation of curcumin-hydroxypropyl-β-cyclodextrin inclusion complex by cosolvency-lyophilization procedure to enhance oral bioavailability of the drug.
    Li N; Wang N; Wu T; Qiu C; Wang X; Jiang S; Zhang Z; Liu T; Wei C; Wang T
    Drug Dev Ind Pharm; 2018 Dec; 44(12):1966-1974. PubMed ID: 30059244
    [TBL] [Abstract][Full Text] [Related]  

  • 4. beta-Cyclodextrin-curcumin self-assembly enhances curcumin delivery in prostate cancer cells.
    Yallapu MM; Jaggi M; Chauhan SC
    Colloids Surf B Biointerfaces; 2010 Aug; 79(1):113-25. PubMed ID: 20456930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anticancer Activity of Novel Difluorinated Curcumin Analog and Its Inclusion Complex with 2-Hydroxypropyl-β-Cyclodextrin against Pancreatic Cancer.
    Bhattacharyya S; Ghosh H; Covarrubias-Zambrano O; Jain K; Swamy KV; Kasi A; Hamza A; Anant S; VanSaun M; Weir SJ; Bossmann SH; Padhye SB; Dandawate P
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Curcumin-cyclodextrin complexes enhanced the anti-cancer effects of curcumin.
    Zhang L; Man S; Qiu H; Liu Z; Zhang M; Ma L; Gao W
    Environ Toxicol Pharmacol; 2016 Dec; 48():31-38. PubMed ID: 27716533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Parenterally administrable nano-micelles of 3,4-difluorobenzylidene curcumin for treating pancreatic cancer.
    Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK
    Colloids Surf B Biointerfaces; 2015 Aug; 132():138-45. PubMed ID: 26037703
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difluorinated Curcumin: A Promising Curcumin Analogue with Improved Anti-Tumor Activity and Pharmacokinetic Profile.
    Momtazi AA; Sahebkar A
    Curr Pharm Des; 2016; 22(28):4386-97. PubMed ID: 27229723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Antitumoral Effect In Ovo of a New Inclusion Complex from Dimethoxycurcumin with Magnesium and Beta-Cyclodextrin.
    Obregón-Mendoza MA; Meza-Morales W; Rodríguez-Hernández KD; Estévez-Carmona MM; Pérez-González LL; Tavera-Hernández R; Ramírez-Apan MT; Barrera-Hernández D; García-Olivares M; Monroy-Torres B; Nieto-Camacho A; Chávez MI; Sánchez-Obregón R; Enríquez RG
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673967
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhancing the solubility and potency of tetrahydrocurcumin as an anti-cancer agent using a β-cyclodextrin inclusion complex approach.
    Low ZX; Teo MYM; Juliana Nordin F; Palanirajan VK; Morak-Młodawska B; Saleem Qazi A; In LLA
    PLoS One; 2024; 19(7):e0305171. PubMed ID: 39058699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluorocurcumins as cyclooxygenase-2 inhibitor: molecular docking, pharmacokinetics and tissue distribution in mice.
    Padhye S; Banerjee S; Chavan D; Pandye S; Swamy KV; Ali S; Li J; Dou QP; Sarkar FH
    Pharm Res; 2009 Nov; 26(11):2438-45. PubMed ID: 19714451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-Circulating Curcumin-Loaded Liposome Formulations with High Incorporation Efficiency, Stability and Anticancer Activity towards Pancreatic Adenocarcinoma Cell Lines In Vitro.
    Mahmud M; Piwoni A; Filipczak N; Janicka M; Gubernator J
    PLoS One; 2016; 11(12):e0167787. PubMed ID: 27936114
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and characterization of folate decorated albumin bio-conjugate nanoparticles loaded with a synthetic curcumin difluorinated analogue.
    Gawde KA; Kesharwani P; Sau S; Sarkar FH; Padhye S; Kashaw SK; Iyer AK
    J Colloid Interface Sci; 2017 Jun; 496():290-299. PubMed ID: 28236692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted anticancer prodrug therapy using dextran mediated enzyme-antibody conjugate and β-cyclodextrin-curcumin inclusion complex.
    Roozbehi S; Dadashzadeh S; Mirshahi M; Sadeghizadeh M; Sajedi RH
    Int J Biol Macromol; 2020 Oct; 160():1029-1041. PubMed ID: 32479931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization and evaluation of a folic acid receptor-targeted cyclodextrin complex as an anticancer drug delivery system.
    Xu J; Xu B; Shou D; Qin F; Xu Y; Hu Y
    Eur J Pharm Sci; 2016 Feb; 83():132-42. PubMed ID: 26577995
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Native and β-cyclodextrin-enclosed curcumin: entrapment within liposomes and their in vitro cytotoxicity in lung and colon cancer.
    Rahman S; Cao S; Steadman KJ; Wei M; Parekh HS
    Drug Deliv; 2012; 19(7):346-53. PubMed ID: 23030405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. pH-tailored delivery of a multitarget anticancer benzimidazole derivative using a PEGylated β-cyclodextrin-curcumin functionalized nanocomplex.
    Shawky H; Fayed DB; Ibrahim NE
    Biomater Adv; 2024 Oct; 163():213964. PubMed ID: 39053387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin-C3 Complexed with α-, β-cyclodextrin Exhibits Antibacterial and Antioxidant Properties Suitable for Cancer Treatments.
    Reddy DNK; Kumar R; Wang SP; Huang FY
    Curr Drug Metab; 2019; 20(12):988-1001. PubMed ID: 31573881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inclusion complex of erlotinib with sulfobutyl ether-β-cyclodextrin: Preparation, characterization, in silico, in vitro and in vivo evaluation.
    Devasari N; Dora CP; Singh C; Paidi SR; Kumar V; Sobhia ME; Suresh S
    Carbohydr Polym; 2015 Dec; 134():547-56. PubMed ID: 26428157
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An optimized molecular inclusion complex of diferuloylmethane: enhanced physical properties and biological activity.
    Tan Q; Li Y; Wu J; Mei H; Zhao C; Zhang J
    Int J Nanomedicine; 2012; 5():5385-93. PubMed ID: 23091376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.